NCT06909149View on ClinicalTrials.gov

Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Amniotic Membrane Extract Eye DropsResistant Corneal Ulcers
Interventions
DRUG

Amniotic membrane extract eye drops

Patients received the amniotic membrane extract eye drops once every two hours during waking time as an adjunctive therapy to the specific treatment.

DRUG

Specific treatment

Patients received the specific treatment only.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06909149 - Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers | Biotech Hunter | Biotech Hunter